Trial · NCT02450552
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Short-interval Intracortical Inhibition (SICI) Measured by Transcranial Magnetic Stimulation (TMS) | Screening, Baseline, Week 6, Week 8 | As a result of electrophysiologic response, good quality data was defined based on the central reader's evaluation. | Unitless | MEAN |
| SECONDARY | Change in Resting Motor Evoked Potential (MEP) Threshold (Prespecified Secondary Outcome of Primary Importance) | Screening, Baseline, Week 6, Week 8 | Data of low quality may have been removed from the number of participants analyzed based on the central reader's evaluation. | percentage of the maximum output | MEAN |
| SECONDARY | Change in MEP Amplitude | Screening, Baseline, Week 6, Week 8 | Data of low quality were removed from analysis as a result of the central reader's evaluation standards. | Millivolts | GEOMETRIC_MEAN |
| SECONDARY | Change in Duration of Cortical Silent Period | Screening, Baseline, Week 6, Week 8 | Data of low quality were removed from analysis population as a result of the central reader's evaluation standards. | Milliseconds | MEAN |
| SECONDARY | Change in Intracortical Facilitation | Screening, Baseline, Week 6, Week 8 | Data of low quality were removed from analysis population as a result of the central reader's evaluation standards. | Unitless | GEOMETRIC_MEAN |
| SECONDARY | Change in Electrotonus | Screening, Baseline, Week 6, Week 8 | Data of low quality were removed from analysis population as a result of the central reader's evaluation standards. | percentage of threshold | MEAN |
| SECONDARY | Change in Strength Duration Time Constant | Screening, Baseline, Week 6, Week 8 | Data of low quality were removed from analysis population as a result of the central reader's evaluation standards. | Milliseconds | MEAN |
| SECONDARY | Change in Recovery Cycle | Screening, Baseline, Week 6, Week 8 | Data of low quality were removed from analysis as a result of the central reader's evaluation standards. | percentage of threshold | MEAN |
| SECONDARY | Muscle Cramping Frequency | Week 1 through Week 10 | Discrepancies in the number of subjects analyzed are a result of subjects with missed data collection during the specific time points. | Days | MEAN |
| SECONDARY | Hand Held Dynamometry Force Measurement for Abductor Pollicis Brevis | Screening, Baseline, Week 4, Week 6, Week 8, Week 12 | Discrepancies in the number of subjects analyzed are a result of subjects with missed data collection during the specific time points. | kilograms (kg) | MEAN |
| SECONDARY | Proportion of Days With Fasciculations | Week 1 through Week 10 | Discrepancies in the number of subjects analyzed are a result of subjects with missed data collection during the specific time points. | Proportion of Days | MEAN |
| SECONDARY | Number of Participants Who Tolerate Study Drug | 10 weeks | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02450552/outcomes